|
|
Line 13: |
Line 13: |
| ===2021: [https://pubmed.ncbi.nlm.nih.gov/33982143/ Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers]=== | | ===2021: [https://pubmed.ncbi.nlm.nih.gov/33982143/ Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers]=== |
| *Reducing nicotine content will likely lower the abuse liability of cigarettes for most young, low-frequency smokers. Additional work is needed to determine if compensatory smoking may lead to increased toxicant exposure, and if a subset of individuals choosing lower nicotine cigarettes may continue to smoke regardless of nicotine content. | | *Reducing nicotine content will likely lower the abuse liability of cigarettes for most young, low-frequency smokers. Additional work is needed to determine if compensatory smoking may lead to increased toxicant exposure, and if a subset of individuals choosing lower nicotine cigarettes may continue to smoke regardless of nicotine content. |
|
| |
|
| |
| ===2021: [https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntab247/6444300 Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers with no Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial]===
| |
| *"This study is the first randomized trial of #ECIGS in which a significant increase in cigarette abstinence compared with placebo ecigs and an alternative non-nicotine cigarette substitute, were observed." [https://twitter.com/JonathanFoulds/status/1465080988258680838 Jonathan Foulds PhD]
| |
| *When smokers seeking to reduce smoking tried ENDS, few quit smoking in the short term. However, if smokers continued to use an ENDS with cigarette-like nicotine delivery, a greater proportion completely switched to ENDS, as compared with placebo or a cigarette substitute.
| |
|
| |
|
|
| |
|